by Maya Koleva | Mar 13, 2024
Reading time: 3 min While Wegovy reshaped public attitudes about obesity, its maker Novo Nordisk oversaw critical reputational threats, highlighting that product success alone cannot safeguard pharma companies without a comprehensive, data-driven reputation management...
by Commetric | Nov 27, 2023
View a one-page infographic summary of the analysis In the past year, celebrities and social media influencers have been taking diabetes treatments for weight loss, sharing their positive results and generating numerous media headlines. The result? An amplified media...
by Commetric | May 30, 2023
Analysing the mental health debate in specialised healthcare media, we found that online therapy providers Talkspace and Headspace emerged as the most influential organisations, while biotech and pharma companies have been lagging behind. We also found that the mental...
by Commetric | Apr 5, 2023
While the debate around PFAS is still focused mainly on the chemicals industry, there is growing media scrutiny of other sectors such as food, cosmetics, retail and fashion. Our analysis suggests that brands producing PFAS could learn some health comms lessons from...
by Commetric | Mar 20, 2023
The recent media debate around popular weight loss drugs such as Wegovy indicated that pharma companies might lack a deeper understanding of how obesity is discussed in the public discourse. Our media analysis around obesity suggested that pharma companies should...